Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer. [electronic resource]

By:

Latteyer, Soeren

Contributor(s):

Tiedje, Vera
König, Katharina
Ting, Saskia
Heukamp, Lukas C
Meder, Lydia
Schmid, Kurt Werner
Führer, Dagmar
Moeller, Lars Christian

Producer: 20170720Description: 733-741 p. digitalISSN:

1559-0100

Subject(s):

Aged
Aged, 80 and over
Anaplastic Lymphoma Kinase
DNA Mutational Analysis
Female
Genes, Neurofibromatosis 1
Genes, p53
Genes, ras
Humans
Male
Middle Aged
Proto-Oncogene Proteins B-raf -- genetics
Receptor Protein-Tyrosine Kinases -- genetics
Thyroid Carcinoma, Anaplastic -- genetics
Thyroid Neoplasms -- genetics

Online resources:

Available from publisher's website

In: Endocrine vol. 54

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer.

APA

Latteyer S., Tiedje V., König K., Ting S., Heukamp L. C., Meder L., Schmid K. W., Führer D. & Moeller L. C. (20170720). Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer. : Endocrine.

Chicago

Latteyer Soeren, Tiedje Vera, König Katharina, Ting Saskia, Heukamp Lukas C, Meder Lydia, Schmid Kurt Werner, Führer Dagmar and Moeller Lars Christian. 20170720. Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer. : Endocrine.

Harvard

Latteyer S., Tiedje V., König K., Ting S., Heukamp L. C., Meder L., Schmid K. W., Führer D. and Moeller L. C. (20170720). Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer. : Endocrine.

MLA

Latteyer Soeren, Tiedje Vera, König Katharina, Ting Saskia, Heukamp Lukas C, Meder Lydia, Schmid Kurt Werner, Führer Dagmar and Moeller Lars Christian. Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer. : Endocrine. 20170720.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC